Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

The influence of Osmunda regalis root extract on head and neck cancer cell proliferation, invasion and gene expression

Authors: Marianne Schmidt, Josef Skaf, Georgiana Gavril, Christine Polednik, Jeanette Roller, Michael Kessler, Ulrike Holzgrabe

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

According to only a handful of historical sources, Osmunda regalis, the royal fern, has been used already in the middle age as an anti-cancer remedy. To examine this ancient cancer cure, an ethanolic extract of the roots was prepared and analysed in vitro on its effectiveness against head and neck cancer cell lines.

Methods

Proliferation inhibition was measured with the MTT assay. Invasion inhibition was tested in a spheroid-based 3-D migration assay on different extracellular matrix surfaces.
Corresponding changes in gene expression were analysed by qRT-PCR array. Induction of apoptosis was measured by fluorescence activated cell sorting (FACS) with the Annexin V binding method. The plant extract was analysed by preliminary phytochemical tests, liquid chromatography/mass spectroscopy (LC-MS) and thin layer chromatography (TLC). Anti-angiogenetic activity was determined by the tube formation assay.

Results

O. regalis extract revealed a growth inhibiting effect on the head and neck carcinoma cell lines HLaC78 and FaDu. The toxic effect seems to be partially modulated by p-glycoprotein, as the MDR-1 expressing HLaC79-Tax cells were less sensitive. O. regalis extract inhibited the invasion of cell lines on diverse extracellular matrix substrates significantly. Especially the dispersion of the highly motile cell line HlaC78 on laminin was almost completely abrogated.
Motility inhibition on laminin was accompanied by differential gene regulation of a variety of genes involved in cell adhesion and metastasis. Furthermore, O. regalis extract triggered apoptosis in HNSCC cell lines and inhibited tube formation of endothelial cells. Preliminary phytochemical analysis proved the presence of tannins, glycosides, steroids and saponins. Liquid chromatography/mass spectroscopy (LC-MS) revealed a major peak of an unknown substance with a molecular mass of 864.15 Da, comprising about 50% of the total extract. Thin layer chromatography identified ferulic acid to be present in the extract.

Conclusion

The presented results justify the use of royal fern extracts as an anti-cancer remedy in history and imply a further analysis of ingredients.
Literature
1.
go back to reference Guntinas-Lichius O, Wendt T, Buentzel J, Esser D, Lochner P, Mueller A, Schultze-Mosgau S, Altendorf-Hofmann A. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol. 2010;136(1):55–63.CrossRefPubMed Guntinas-Lichius O, Wendt T, Buentzel J, Esser D, Lochner P, Mueller A, Schultze-Mosgau S, Altendorf-Hofmann A. Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol. 2010;136(1):55–63.CrossRefPubMed
2.
go back to reference Harrison LB, Sessions RB, Kies MS. Head and neck cancer: a multidisciplinary approach. 4th ed: Lippincott Williams and Wilkins; 2013. Harrison LB, Sessions RB, Kies MS. Head and neck cancer: a multidisciplinary approach. 4th ed: Lippincott Williams and Wilkins; 2013.
3.
go back to reference Pfreundner L, Hoppe F, Willner J, Preisler V, Bratengeier K, Hagen R, Helms J, Flentje M. Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation. Radiother Oncol. 2003;68(2):163–70.CrossRefPubMed Pfreundner L, Hoppe F, Willner J, Preisler V, Bratengeier K, Hagen R, Helms J, Flentje M. Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation. Radiother Oncol. 2003;68(2):163–70.CrossRefPubMed
4.
go back to reference Will H: Vergleich der Indikationen des ‚Kleinen Destillierbuches’ des Chirurgen Hieronymus Brunschwig (Straßburg 1500) mit den nach derzeitigem wissenschaftlichem Erkenntnisstand belegten Indikationen. Wuerzburg: Julius-Maximilians-Universität Würzburg; 2009. Will H: Vergleich der Indikationen des ‚Kleinen Destillierbuches’ des Chirurgen Hieronymus Brunschwig (Straßburg 1500) mit den nach derzeitigem wissenschaftlichem Erkenntnisstand belegten Indikationen. Wuerzburg: Julius-Maximilians-Universität Würzburg; 2009.
5.
go back to reference Hartwell JL. Plants used against cancer. Massachusetts USA: Quarterman Publications, Inc.; 1982. Hartwell JL. Plants used against cancer. Massachusetts USA: Quarterman Publications, Inc.; 1982.
6.
go back to reference Williams S. Report on the indigenous medical botany of Massachusetts. Trans Amer Med Assoc. 1849;2:863–927. Williams S. Report on the indigenous medical botany of Massachusetts. Trans Amer Med Assoc. 1849;2:863–927.
7.
go back to reference Thomas T. Preliminary antibacterial and phytochemical assessment of Osmunda Regalis L. Int J Pharmaceut Biol Arch. 2011;2(1):559–62. Thomas T. Preliminary antibacterial and phytochemical assessment of Osmunda Regalis L. Int J Pharmaceut Biol Arch. 2011;2(1):559–62.
8.
go back to reference Zenner HPLW, Herrmann IF. Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol. 1979;225(4):269–77.CrossRefPubMed Zenner HPLW, Herrmann IF. Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol. 1979;225(4):269–77.CrossRefPubMed
9.
go back to reference Yadav MCS, Gupta SK, Watal G. Preliminary phytochemical screening of six medicinal plants used in traditional medicine. Int J Pharmacy Pharmaceut Sci. 2014;6(5):539–42. Yadav MCS, Gupta SK, Watal G. Preliminary phytochemical screening of six medicinal plants used in traditional medicine. Int J Pharmacy Pharmaceut Sci. 2014;6(5):539–42.
10.
go back to reference Jaradad NHF, Al Ali A. Preliminary phytochemical screening, quantitative estimation of Total flavonoids, Total phenols and antioxidant activity of Ephedra Alata Decne. J Mater Environ Sci. 2015;6(6):1771–8. Jaradad NHF, Al Ali A. Preliminary phytochemical screening, quantitative estimation of Total flavonoids, Total phenols and antioxidant activity of Ephedra Alata Decne. J Mater Environ Sci. 2015;6(6):1771–8.
11.
go back to reference Wagner HBS. Plant drug analyses – a thin layer cromatography atlas, 2nd edn. Berlin, Heidelberg. New York: Springer Verlag; 1996. Wagner HBS. Plant drug analyses – a thin layer cromatography atlas, 2nd edn. Berlin, Heidelberg. New York: Springer Verlag; 1996.
12.
go back to reference Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1):55–63.CrossRefPubMed Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1):55–63.CrossRefPubMed
13.
go back to reference van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31(1):1–9.CrossRefPubMed van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31(1):1–9.CrossRefPubMed
14.
go back to reference Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D, Eccles SA. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29.CrossRefPubMedPubMedCentral Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D, Eccles SA. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10:29.CrossRefPubMedPubMedCentral
15.
go back to reference Vinci M, Box C, Zimmermann M, Eccles SA. Tumor spheroid-based migration assays for evaluation of therapeutic agents. Methods Mol Biol. 2013;986:253–66.CrossRefPubMed Vinci M, Box C, Zimmermann M, Eccles SA. Tumor spheroid-based migration assays for evaluation of therapeutic agents. Methods Mol Biol. 2013;986:253–66.CrossRefPubMed
16.
go back to reference Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′----3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88(16):7276–80.CrossRefPubMedPubMedCentral Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′----3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88(16):7276–80.CrossRefPubMedPubMedCentral
17.
go back to reference Schmidt M, Scholz C, Gavril G, Otto C, Polednik C, Roller J, Hagen R. Effect of Galium Verum aqueous extract on growth, motility and gene expression in drug-sensitive and -resistant laryngeal carcinoma cell lines. Int J Oncol. 2014;44(3):745–60.CrossRefPubMed Schmidt M, Scholz C, Gavril G, Otto C, Polednik C, Roller J, Hagen R. Effect of Galium Verum aqueous extract on growth, motility and gene expression in drug-sensitive and -resistant laryngeal carcinoma cell lines. Int J Oncol. 2014;44(3):745–60.CrossRefPubMed
18.
19.
go back to reference Schmidt M, Polednik C, Roller J, Hagen R. Galium Verum aqueous extract strongly inhibits the motility of head and neck cancer cell lines and protects mucosal keratinocytes against toxic DNA damage. Oncol Rep. 2014;32(3):1296–302.CrossRefPubMed Schmidt M, Polednik C, Roller J, Hagen R. Galium Verum aqueous extract strongly inhibits the motility of head and neck cancer cell lines and protects mucosal keratinocytes against toxic DNA damage. Oncol Rep. 2014;32(3):1296–302.CrossRefPubMed
20.
go back to reference Zhang X, Lin D, Jiang R, Li H, Wan J, Li H. Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol Rep. 2016;36(1):271–8.CrossRefPubMed Zhang X, Lin D, Jiang R, Li H, Wan J, Li H. Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol Rep. 2016;36(1):271–8.CrossRefPubMed
21.
go back to reference Iizuka S, Ishimaru N, Kudo Y. Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression. Cancers. 2014;6(1):396–415.CrossRefPubMedPubMedCentral Iizuka S, Ishimaru N, Kudo Y. Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression. Cancers. 2014;6(1):396–415.CrossRefPubMedPubMedCentral
22.
go back to reference Tan Ide A, Ricciardelli C, Russell DL. The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways. Int J Cancer. 2013;133(10):2263–76.CrossRefPubMed Tan Ide A, Ricciardelli C, Russell DL. The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways. Int J Cancer. 2013;133(10):2263–76.CrossRefPubMed
23.
go back to reference Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massague J, Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009;23(16):1882–94.CrossRefPubMedPubMedCentral Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massague J, Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009;23(16):1882–94.CrossRefPubMedPubMedCentral
24.
go back to reference Kuang J, Zhao M, Li H, Dang W, Li W. Identification of potential therapeutic target genes and mechanisms in head and neck squamous cell carcinoma by bioinformatics analysis. Oncol Lett. 2016;11(5):3009–14.PubMedPubMedCentral Kuang J, Zhao M, Li H, Dang W, Li W. Identification of potential therapeutic target genes and mechanisms in head and neck squamous cell carcinoma by bioinformatics analysis. Oncol Lett. 2016;11(5):3009–14.PubMedPubMedCentral
26.
go back to reference Jayachandran A, Anaka M, Prithviraj P, Hudson C, McKeown SJ, Lo PH, Vella LJ, Goding CR, Cebon J, Behren A. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget. 2014;5(14):5782–97.CrossRefPubMedPubMedCentral Jayachandran A, Anaka M, Prithviraj P, Hudson C, McKeown SJ, Lo PH, Vella LJ, Goding CR, Cebon J, Behren A. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget. 2014;5(14):5782–97.CrossRefPubMedPubMedCentral
27.
go back to reference Roberts DD. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 1996;10(10):1183–91.PubMed Roberts DD. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 1996;10(10):1183–91.PubMed
28.
go back to reference Lowy CM, Oskarsson T, Tenascin C. In metastasis: a view from the invasive front. Cell Adhes Migr. 2015;9(1–2):112–24.CrossRef Lowy CM, Oskarsson T, Tenascin C. In metastasis: a view from the invasive front. Cell Adhes Migr. 2015;9(1–2):112–24.CrossRef
29.
go back to reference Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, et al. Versican promotes tumor progression, metastasis and predicts poor prognosis in renal carcinoma. Mol Cancer Res. 2017;15(7):884–95.CrossRefPubMed Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, et al. Versican promotes tumor progression, metastasis and predicts poor prognosis in renal carcinoma. Mol Cancer Res. 2017;15(7):884–95.CrossRefPubMed
30.
go back to reference Arellano-Garcia ME, Li R, Liu X, Xie Y, Yan X, Loo JA, Hu S. Identification of tetranectin as a potential biomarker for metastatic oral cancer. Int J Mol Sci. 2010;11(9):3106–21.CrossRefPubMedPubMedCentral Arellano-Garcia ME, Li R, Liu X, Xie Y, Yan X, Loo JA, Hu S. Identification of tetranectin as a potential biomarker for metastatic oral cancer. Int J Mol Sci. 2010;11(9):3106–21.CrossRefPubMedPubMedCentral
31.
go back to reference Yang GW, Jiang JS, Lu WQ. Ferulic acid exerts anti-Angiogenic and anti-tumor activity by targeting fibroblast growth factor receptor 1-mediated angiogenesis. Int J Mol Sci. 2015;16(10):24011–31.CrossRefPubMedPubMedCentral Yang GW, Jiang JS, Lu WQ. Ferulic acid exerts anti-Angiogenic and anti-tumor activity by targeting fibroblast growth factor receptor 1-mediated angiogenesis. Int J Mol Sci. 2015;16(10):24011–31.CrossRefPubMedPubMedCentral
Metadata
Title
The influence of Osmunda regalis root extract on head and neck cancer cell proliferation, invasion and gene expression
Authors
Marianne Schmidt
Josef Skaf
Georgiana Gavril
Christine Polednik
Jeanette Roller
Michael Kessler
Ulrike Holzgrabe
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-2009-4

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue